Table 2 Clinicopathological features per CD1a+ DC infiltration
CD1a Low (n = 29) | CD1a High (n = 28) | P-value | |
|---|---|---|---|
Age, years (mean ± SD) | 68.9 ± 8.4 | 67.9 ± 9.3 | 0.682 |
Sex | |||
Male | 28 (96.6%) | 26 (92.9%) | 0.532 |
Female | 1 (3.4%) | 2 (7.1%) | |
Subsite | |||
Glottic | 17 (58.6%) | 18 (64.3%) | 0.661 |
Supra/Sub | 12 (41.4%) | 10 (35.7%) | |
Histology | |||
Well | 16 (55.2%) | 14 (50.0%) | 0.696 |
Mode/poor | 13 (44.8%) | 14 (50.0%) | |
T stage | |||
T2/T3 | 17 (58.6%) | 9 (32.1%) | 0.045 |
T4 | 12 (41.4%) | 19 (67.9%) | |
N stage | |||
N0 | 20 (69.0%) | 17 (60.7%) | 0.514 |
N1–3 | 9 (31.0%) | 11 (39.3%) | |
M stage (%) | |||
M0 | 28 (96.6%) | 28 (100.0%) | 0.321 |
M1 | 1 (3.4%) | 0 (0.0%) | |
Stage | |||
III | 14 (48.3%) | 6 (21.4%) | 0.034 |
IV | 15 (51.7%) | 22 (78.6%) | |
CD8+ CTLs | 510.7 ± 582.6 | 616.7 ± 415.6 | 0.428 |
Adjuvant therapy | |||
(−) | 8 (27.6%) | 11 (39.3%) | 0.349 |
(+) | 21 (72.4%) | 17 (60.7%) | |